Table 2. Trend in vector infectivity rate in the R. Bakoye focus.
| Phase 1* (after 15 years Rx) | Phase 2* (1.5 years after last Rx in test area) | Phase 3A (1.5–2.5 years after last Rx) | Phase 3B (2.5–3.5 years after last Rx) | |||||||
| Catching points | Infectivity rate (F3H/1000) | Infectivity rate (F3H/1000) | Flies examined | Infectivity rate (F3H/1000) | 95% confidence interval | Flies examined | Infectivity rate (F3H/1000) | 95% confidence interval | ||
| Badala | 0.20 | 0.00 | 7,200 | 0.00 | 0.00 | 0.26 | 7,500 | 0.00 | 0.00 | 0.26 |
| Kolontan | 0.00 | 0.00 | 16,500 | 0.00 | 0.00 | 0.12 | 21,300 | 0.00 | 0.00 | 0.09 |
| Tieourou | 0.23 | 0.00 | 10,500 | 0.00 | 0.00 | 0.18 | 10,500 | 0.00 | 0.00 | 0.18 |
| Toufinko | 0.00 | 0.00 | 15,600 | 0.00 | 0.00 | 0.12 | 17,400 | 0.00 | 0.00 | 0.11 |
| Total | 0.14 | 0.00 | 49,800 | 0.00 | 0.00 | 0.04 | 56,700 | 0.00 | 0.00 | 0.03 |
Source: Diawara et al [17].